The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pain Management Drugs Market Research Report 2024

Global Pain Management Drugs Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1383357

No of Pages : 93

Ask Your Query

Synopsis
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

This report is mainly about the drugs for pain management.

The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.

The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.

This report aims to provide a comprehensive presentation of the global market for Pain Management Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Management Drugs.

Report Scope

The Pain Management Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pain Management Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pain Management Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company (Partial List):

  • GSK
  • Pfizer
  • Grunenthal
  • Sanofi
  • Bayer
  • AstraZeneca
  • Eli Lilly
  • Endo
  • Merck
  • Yunnan Baiyao
  • Teikoku Seiyaku
  • Teva
  • J&J
  • Assertio Therapeutics
  • Allergan

Segment by Type

  • Generic Opioids
  • Branded Opioids
  • NSAIDs
  • Others

Segment by Application

  • Hospitals
  • Drugstores
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pain Management Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pain Management Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Generic Opioids
1.2.3 Branded Opioids
1.2.4 NSAIDs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pain Management Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pain Management Drugs Market Perspective (2019-2030)
2.2 Pain Management Drugs Growth Trends by Region
2.2.1 Global Pain Management Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pain Management Drugs Historic Market Size by Region (2019-2024)
2.2.3 Pain Management Drugs Forecasted Market Size by Region (2025-2030)
2.3 Pain Management Drugs Market Dynamics
2.3.1 Pain Management Drugs Industry Trends
2.3.2 Pain Management Drugs Market Drivers
2.3.3 Pain Management Drugs Market Challenges
2.3.4 Pain Management Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pain Management Drugs Players by Revenue
3.1.1 Global Top Pain Management Drugs Players by Revenue (2019-2024)
3.1.2 Global Pain Management Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Pain Management Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pain Management Drugs Revenue
3.4 Global Pain Management Drugs Market Concentration Ratio
3.4.1 Global Pain Management Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pain Management Drugs Revenue in 2023
3.5 Pain Management Drugs Key Players Head office and Area Served
3.6 Key Players Pain Management Drugs Product Solution and Service
3.7 Date of Enter into Pain Management Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pain Management Drugs Breakdown Data by Type
4.1 Global Pain Management Drugs Historic Market Size by Type (2019-2024)
4.2 Global Pain Management Drugs Forecasted Market Size by Type (2025-2030)
5 Pain Management Drugs Breakdown Data by Application
5.1 Global Pain Management Drugs Historic Market Size by Application (2019-2024)
5.2 Global Pain Management Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pain Management Drugs Market Size (2019-2030)
6.2 North America Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pain Management Drugs Market Size by Country (2019-2024)
6.4 North America Pain Management Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pain Management Drugs Market Size (2019-2030)
7.2 Europe Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pain Management Drugs Market Size by Country (2019-2024)
7.4 Europe Pain Management Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pain Management Drugs Market Size (2019-2030)
8.2 Asia-Pacific Pain Management Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pain Management Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Pain Management Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pain Management Drugs Market Size (2019-2030)
9.2 Latin America Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pain Management Drugs Market Size by Country (2019-2024)
9.4 Latin America Pain Management Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pain Management Drugs Market Size (2019-2030)
10.2 Middle East & Africa Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pain Management Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Pain Management Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Pain Management Drugs Introduction
11.1.4 GSK Revenue in Pain Management Drugs Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Pain Management Drugs Introduction
11.2.4 Pfizer Revenue in Pain Management Drugs Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Grunenthal
11.3.1 Grunenthal Company Detail
11.3.2 Grunenthal Business Overview
11.3.3 Grunenthal Pain Management Drugs Introduction
11.3.4 Grunenthal Revenue in Pain Management Drugs Business (2019-2024)
11.3.5 Grunenthal Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Pain Management Drugs Introduction
11.4.4 Sanofi Revenue in Pain Management Drugs Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Pain Management Drugs Introduction
11.5.4 Bayer Revenue in Pain Management Drugs Business (2019-2024)
11.5.5 Bayer Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Pain Management Drugs Introduction
11.6.4 AstraZeneca Revenue in Pain Management Drugs Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Detail
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Pain Management Drugs Introduction
11.7.4 Eli Lilly Revenue in Pain Management Drugs Business (2019-2024)
11.7.5 Eli Lilly Recent Development
11.8 Endo
11.8.1 Endo Company Detail
11.8.2 Endo Business Overview
11.8.3 Endo Pain Management Drugs Introduction
11.8.4 Endo Revenue in Pain Management Drugs Business (2019-2024)
11.8.5 Endo Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck Pain Management Drugs Introduction
11.9.4 Merck Revenue in Pain Management Drugs Business (2019-2024)
11.9.5 Merck Recent Development
11.10 Yunnan Baiyao
11.10.1 Yunnan Baiyao Company Detail
11.10.2 Yunnan Baiyao Business Overview
11.10.3 Yunnan Baiyao Pain Management Drugs Introduction
11.10.4 Yunnan Baiyao Revenue in Pain Management Drugs Business (2019-2024)
11.10.5 Yunnan Baiyao Recent Development
11.11 Teikoku Seiyaku
11.11.1 Teikoku Seiyaku Company Detail
11.11.2 Teikoku Seiyaku Business Overview
11.11.3 Teikoku Seiyaku Pain Management Drugs Introduction
11.11.4 Teikoku Seiyaku Revenue in Pain Management Drugs Business (2019-2024)
11.11.5 Teikoku Seiyaku Recent Development
11.12 Teva
11.12.1 Teva Company Detail
11.12.2 Teva Business Overview
11.12.3 Teva Pain Management Drugs Introduction
11.12.4 Teva Revenue in Pain Management Drugs Business (2019-2024)
11.12.5 Teva Recent Development
11.13 J&J
11.13.1 J&J Company Detail
11.13.2 J&J Business Overview
11.13.3 J&J Pain Management Drugs Introduction
11.13.4 J&J Revenue in Pain Management Drugs Business (2019-2024)
11.13.5 J&J Recent Development
11.14 Assertio Therapeutics
11.14.1 Assertio Therapeutics Company Detail
11.14.2 Assertio Therapeutics Business Overview
11.14.3 Assertio Therapeutics Pain Management Drugs Introduction
11.14.4 Assertio Therapeutics Revenue in Pain Management Drugs Business (2019-2024)
11.14.5 Assertio Therapeutics Recent Development
11.15 Allergan
11.15.1 Allergan Company Detail
11.15.2 Allergan Business Overview
11.15.3 Allergan Pain Management Drugs Introduction
11.15.4 Allergan Revenue in Pain Management Drugs Business (2019-2024)
11.15.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock